查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2004649

血液採集設備市場：按產品類型、技術、材料、應用和最終用戶分類的全球市場預測，2026-2032年

Blood Collection Devices Market by Product Type, Technology, Material, Application, End Users - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年血液採集設備市場價值為81.8億美元，預計到2026年將成長至86.6億美元，複合年成長率為6.14%，到2032年將達到124.3億美元。

主要市場統計數據
基準年 2025 81.8億美元
預計年份：2026年 86.6億美元
預測年份 2032 124.3億美元
複合年成長率 (%) 6.14%

血液採集設備生態系統概述，包括臨床因素、監管要求、製造複雜性和策略重點。

血液採集設備產業處於臨床需求、監管和製造複雜性的交匯點，因此創新與可靠性必須並存。診斷技術的進步、對病人安全的日益重視以及醫療服務模式的轉變，都提升了能夠可靠採集和儲存生物檢體的設備的重要性。因此，整個價值鏈上的相關人員——包括製造商、臨床檢查室、採購負責人和醫療服務提供者——都必須應對不斷變化的技術標準、材料選擇和營運預期。

策略考量：影響設備設計、監管預期、供應鏈韌性和永續性優先事項的變革性因素。

近年來，醫療領域發生了變革性的變化，重新定義了血液採集設備的設計、製造和部署方式。尤其值得關注的是科技的融合。自動化、封閉式系統設計和整合分析功能降低了分析前變異性，同時提高了中心檢查室的處理能力。同時，居家採血和就地檢驗的日益普及，使得使用者對操作簡單、穩定性強的設備提出了更高的要求，迫使製造商重新思考人體工學和防腐劑的化學性質。

分析檢視了近期美國關稅政策如何重塑籌資策略、生產地點、採購合約和產品開發決策。

美國2025年實施的新關稅措施對血液採集設備生態系統中相關人員的供應鏈、採購決策和產品成本結構產生了多方面的影響。短期內，依賴進口原料和成品組件的製造商面臨到貨成本上漲的壓力，迫使他們與供應商重新談判合約並重新評估生產基地。這些成本波動促使採購團隊更仔細地檢視整體擁有成本，並評估短期價格調整是暫時的，還是長期採購複雜性的徵兆。

基於細分市場的詳細分析揭示了產品類型、技術選擇、材料選擇、臨床應用和最終用戶需求如何影響策略產品和商業決策。

深入的市場細分揭示了血液採集設備領域內不同產品類型和終端用戶需求所受到的獨特技術和商業性動態影響。產品類型的差異凸顯了性能和監管重點的不同。血袋需要強大的防漏性能、檢驗的滅菌方法和可靠的標籤檢視系統。採血針需要穩定的穿刺性能和生物相容性表面處理，其中注射針和真空針各自具有獨特的操作和安全注意事項。血液採集管路包括EDTA管路、肝素管路、血漿管路和血清管路，以及特殊配方和添加劑的管理。採血採血針優先考慮易用性、最大限度減少疼痛和安全處置。

美洲、歐洲、中東和非洲以及亞太地區的趨勢如何影響採購、監管、製造和臨床部署的區域觀點。

區域趨勢持續影響全球血液採集設備市場的策略重點和競爭定位。在美洲，完善的捐血基礎設施、先進的偵測網路和集中採購管道，使得產品效能、可追溯性和供應商可靠性至關重要。該地區的醫療機構通常要求快速獲得監管文件、完善的上市後監管以及支援庫存管理和臨床培訓的夥伴關係模式，這使得能夠提供除設備產品組合外的綜合服務的供應商更具優勢。

策略性地整合競爭行動，展現創新、監管意識、供應鏈管理和基於服務的差異化如何決定領導力和韌性。

主要企業之間的競爭格局是由產品創新、監管專業知識、供應鏈管理以及醫療設備本身以外的附加價值服務共同驅動的。市場領導正投資於自動化平台和整合數位解決方案，以增強分析前可追溯性和檢查室工作流程；而專業公司則專注於利基產品，例如新型試管化學技術和符合人體工學設計的採血針系統，以應對特定的臨床挑戰。醫療設備製造商和診斷設備供應商之間的策略合作日益普遍，從而能夠提供捆綁式服務，最佳化從檢體到結果的整個流程。

為高階主管提供一套切實可行的策略行動方案，以增強供應鏈韌性、加速創新應用、提升監管應對力並建立基於服務的差異化優勢。

產業領導者應採取協作方式，將產品創新、供應鏈韌性和商業性執行相結合，以維持成長並降低風險。首先，透過認證多家供應商並建立區域製造方案，實現籌資策略多元化，從而減輕貿易中斷和關稅波動的影響。投資短期雙重採購和策略性庫存緩衝，可在實施長期在地化計畫的同時保障業務永續營運。其次，在臨床和營運效益足以支撐資本投入的情況下，加速採用自動化和封閉式系統設計，同時為小批量生產和分散式環境提供經濟高效的手動替代方案。

本文概述了支撐這項分析的透明調查方法，描述了關鍵相關人員的參與、第二手資料的整合、檢驗方法和品質保證流程。

本分析所依據的研究透過結合與相關人員的定性對話、對第二手資料的嚴格整合以及資料三角驗證，確保了分析結果的平衡性和可操作性。主要研究包括對臨床檢查室經理、採購負責人、製造主管和法規遵從專家進行結構化檢驗，以獲取關於醫療設備性能、採購限制和推廣應用促進因素的第一手觀點。從這些對話中獲得的見解構成了一個分類系統的基礎，該系統用於對產品類型、技術、材料、應用和最終用戶場景進行分類，從而能夠進行反映實際營運的重點分析。

整合簡潔明了的結論，明確界定了策略重點、營運挑戰以及在整個生態系統中實現臨床和商業性價值所需的行動。

總而言之，在技術創新、監管要求不斷提高以及供應鏈動態變化的驅動下，血液採集設備市場格局正經歷重大變革。這些因素正在重塑產品設計重點，加速高通量環境下自動化技術的應用，並凸顯在不斷變化的貿易政策背景下，制定具有韌性的籌資策略的重要性。同時，產品類型、技術、材料、臨床應用和終端用戶場景等方面的細微差異，也凸顯了製定兼顧性能、成本和合規性的個人化方案的必要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 血液採集設備市場：依產品類型分類

  • 採血袋
  • 採血針
    • 針頭
    • 真空針
  • 採血管
    • EDTA管
    • 肝素管
    • 電漿管
    • 血清管
  • 採血採血針

第9章 血液採集設備市場：依技術分類

  • 自動採血裝置
  • 手動採血裝置

第10章：採血設備市場：依材料分類

  • 玻璃
  • 塑膠
  • 橡皮
  • 不銹鋼

第11章 血液採集設備市場：依應用領域分類

  • 診斷
  • 治療

第12章 血液採集設備市場：依最終用戶分類

  • 捐血中心
  • 診斷中心和病理檢查室
  • 醫院和診所

第13章 血液採集設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 血液採集設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 血液採集設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國採血設備市場

第17章：中國採血設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • AdvaCare Pharma
  • Avanos Medical, Inc.
  • Avantor, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biosigma SpA
  • Cardinal Health, Inc.
  • Exelint International, Co.
  • Fresenius SE & Co. KGaA
  • Greiner AG
  • Haemonetics Corporation by GVS SpA
  • ICU Medical, Inc.
  • Kawasumi Laboratories America, Inc.
  • Lasany International
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Nipro Corporation
  • Sarstedt AG & Co. KG
  • Sekisui Medical Co., Ltd.
  • Siemens Healthineers AG
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-742BD517BE69

The Blood Collection Devices Market was valued at USD 8.18 billion in 2025 and is projected to grow to USD 8.66 billion in 2026, with a CAGR of 6.14%, reaching USD 12.43 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.18 billion
Estimated Year [2026] USD 8.66 billion
Forecast Year [2032] USD 12.43 billion
CAGR (%) 6.14%

A comprehensive orientation to the blood collection device ecosystem that frames clinical drivers, regulatory demands, manufacturing complexity and strategic priorities

The blood collection device arena sits at the intersection of clinical need, regulatory scrutiny, and manufacturing complexity, creating a landscape where innovation and reliability must coexist. Advances in diagnostics, the growing emphasis on patient safety, and shifts in healthcare delivery models are elevating the strategic importance of devices that reliably obtain and preserve biological specimens. Consequently, stakeholders across the value chain-manufacturers, clinical laboratories, procurement professionals, and healthcare providers-must navigate evolving technical standards, material choices, and operational expectations.

Transitioning from traditional supply paradigms, industry participants are responding to demands for higher throughput, more consistent sample integrity, and enhanced user safety. Simultaneously, environmental considerations and circularity targets are prompting re-evaluation of materials and single-use formats. These combined pressures require organizations to balance short-term operational continuity with long-term strategic investments in automation, supply resilience, and regulatory preparedness. The introduction lays the groundwork for deeper analysis by framing the core drivers, risk vectors, and value opportunities that shape decision-making for manufacturers and institutional buyers alike.

A strategic examination of the transformative forces reshaping device design, regulatory expectations, supply chain resilience and sustainability priorities

Recent years have produced transformational shifts that are reshaping how blood collection devices are designed, manufactured, and deployed across care settings. Technological convergence is particularly notable: automation, closed-system designs, and integrated analytics are reducing pre-analytical variability while enabling higher throughput in centralized laboratories. At the same time, the rise of home-collection and point-of-care testing has amplified the need for user-friendly devices and robust stability profiles, prompting manufacturers to rethink ergonomics and preservative chemistry.

Regulatory and policy shifts are also catalyzing change. Heightened attention to adverse events, traceability requirements, and sterilization documentation has driven stronger post-market surveillance and more rigorous design controls. In parallel, supply chain realignment-motivated by both geopolitical uncertainty and a desire for regional self-sufficiency-has encouraged investments in localized manufacturing and dual-sourcing strategies. Moreover, sustainability commitments from hospitals and procurement consortia are influencing material selection and end-of-life considerations, nudging the industry toward alternatives to traditional plastics and greater use of recyclable or lower-impact components.

Together, these disruptive forces are fostering a competitive environment where speed to regulatory approval, the ability to demonstrate reliable clinical performance, and resilience of supply chains determine which companies will lead the next phase of industry evolution. As a result, organizations that integrate technological innovation with pragmatic supply and regulatory strategies are positioned to capture expanded clinical adoption and strengthen customer trust.

An analytical narrative on how recent United States tariff policies have reshaped sourcing strategies, production footprints, procurement contracts and product development decisions

The introduction of new tariff measures in the United States during 2025 has exerted layered effects across supply chains, procurement decisions, and product cost structures for stakeholders in the blood collection device ecosystem. In the immediate term, manufacturers that rely on imported raw materials or finished components experienced upward pressure on landed costs, which necessitated renegotiation of supplier contracts and reassessment of production footprints. These cost dynamics encouraged procurement teams to scrutinize total cost of ownership more closely, evaluating whether near-term price adjustments were temporary or indicative of longer-term sourcing complexity.

In response, many organizations accelerated diversification strategies by qualifying secondary suppliers, increasing inventory buffers for critical items, and exploring regional manufacturing partnerships that reduce exposure to cross-border duties. This strategic pivot carried operational trade-offs: while localization can mitigate tariff exposure, it may require significant capital expenditure or compromise on supplier specialization. Over time, the tariff environment also influenced product development decisions, encouraging designs that minimize reliance on imported subassemblies and that favor materials available from domestic or allied sources.

From a commercial perspective, buyers adjusted tender frameworks and procurement schedules to maintain supply continuity and price predictability. Meanwhile, companies with vertically integrated capabilities or established regional manufacturing hubs found opportunities to strengthen customer relationships by offering more predictable lead times and simplified compliance documentation. Looking ahead, the cumulative impacts of tariff-driven adjustments reinforce the importance of adaptable sourcing policies and proactive engagement with procurement partners to sustain margins and service levels in a shifting trade environment.

A deep segmentation-led analysis revealing how product types, technology choices, material selections, clinical applications and end-user needs shape strategic product and commercial decisions

Insightful segmentation illuminates the distinct technical and commercial dynamics that govern different product categories and end-user needs within the blood collection device space. Product type distinctions reveal divergent performance and regulatory priorities: Blood Bags require robust leak resistance, validated sterilization approaches, and secure labeling systems; Blood Collection Needles demand consistent puncture performance and biocompatible finishes, with syringe needles and vacuum needles each presenting unique handling and safety considerations; Blood Collection Tubes encompass specialized formulations and additive management across EDTA tubes, Heparin tubes, Plasma Blood tubes, and Serum tubes; and Blood Lancets emphasize ease of use, minimized pain, and safe disposal.

Technology segmentation differentiates opportunities and adoption pathways across automated blood collection devices and manual blood collection devices. Automation appeals to high-throughput laboratories and centralized blood banks seeking reduced variability and enhanced traceability, whereas manual devices remain prevalent in decentralized settings, smaller clinics, and certain point-of-care scenarios where cost and simplicity drive selection. Material choices further nuance product strategies, as glass offers inert properties ideal for some analytical workflows while plastic provides weight, breakage resistance, and cost advantages; rubber components influence sealing integrity and shelf life; and stainless steel dominates sharps that require precise machining and corrosion resistance.

Application-oriented segmentation separates diagnostic and therapeutic use cases, each imposing different validation, handling, and stability requirements. Diagnostics prioritize pre-analytical integrity and compatibility with downstream assays, while therapeutic applications may require specialized storage, compatibility with transfusion workflows, and traceability for clinical interventions. Finally, end-user segmentation-spanning blood donation centers, diagnostic centers and pathology laboratories, and hospitals and clinics-drives procurement patterns, capital allocation, and service-level demands. Blood donation centers prioritize donor safety and throughput, diagnostic centers emphasize compatibility with laboratory analyzers and sample stability, and hospitals and clinics require versatile devices that support a wide range of clinical procedures. Recognizing these layered segment distinctions helps firms tailor product portfolios, quality systems, and commercial approaches to address specific clinical, regulatory, and operational requirements effectively.

A nuanced regional perspective on how the Americas, Europe Middle East and Africa, and Asia-Pacific dynamics influence procurement, regulation, manufacturing and clinical adoption

Regional dynamics continue to influence strategic priorities and competitive positioning across the global landscape for blood collection devices. In the Americas, established blood donation infrastructures, sophisticated laboratory networks, and concentrated procurement channels create an environment where product performance, traceability, and supplier reliability are paramount. Providers in this region often demand rapid regulatory documentation, robust post-market surveillance, and partnership models that support inventory management and clinical training, which favors suppliers capable of delivering comprehensive service offerings alongside device portfolios.

Across Europe, the Middle East and Africa, regulatory heterogeneity and diverse healthcare delivery models produce a wide range of adoption curves and procurement behaviors. Western European markets emphasize stringent conformity assessment and environmental compliance, incentivizing premium devices and strong supplier certification paths. Meanwhile, markets within the broader region may prioritize cost-effective solutions and adaptable supply arrangements, and this diversity requires manufacturers to adopt flexible commercial strategies and regional regulatory expertise. Transitional healthcare systems in parts of the region present opportunities for targeted investments in training, supply chain development, and localized product customization.

The Asia-Pacific region exhibits rapid uptake of both centralized laboratory automation and decentralized testing models, driven by expanding healthcare access, rising screening initiatives, and growing local manufacturing capacity. Producers and distributors in Asia-Pacific are increasingly focused on scalability, cost-competitive manufacturing, and the ability to meet diverse regulatory regimes quickly. Additionally, Asia-Pacific serves as a critical production hub for many global players, and regional policies that encourage domestic manufacturing have prompted investments in capacity expansion, creating interdependencies between trade policies and supply availability worldwide. Together, these regional characteristics inform differentiated go-to-market tactics, regulatory planning, and manufacturing investments.

A strategic synthesis of competitive behavior showing how innovation, regulatory mastery, supply chain control and services-based differentiation determine leadership and resilience

Competitive dynamics among leading companies are driven by a combination of product innovation, regulatory expertise, supply chain control, and value-added services that extend beyond the device itself. Market leaders are investing in automation platforms and integrated digital solutions that enhance pre-analytical traceability and laboratory workflows, while specialized players focus on niche product excellence-such as novel tube chemistries or ergonomic lancet systems-that solve specific clinical pain points. Strategic partnerships between device manufacturers and diagnostic instrument providers are increasingly common, enabling bundled offerings that optimize sample-to-result pathways.

Consolidation activity and strategic alliances reflect a drive to capture complementary capabilities, scale regulatory operations, and secure supplier networks. In parallel, a subset of companies pursues regional manufacturing investments to reduce trade exposure and accelerate product registration, while others prioritize strengthening aftermarket services, including training, technical support, and consumable replenishment programs that increase customer stickiness. Product differentiation often hinges on documented stability claims, sterilization validation, and quality management certifications, which inform procurement decisions and reimbursement conversations. Ultimately, firms that align innovation with operational excellence and robust regulatory pathways are positioned to deepen market penetration and foster long-term customer partnerships.

A practical set of strategic actions for executives to strengthen supply resilience, accelerate innovation adoption, elevate regulatory readiness and embed services-based differentiation

Industry leaders should pursue coordinated actions that align product innovation, supply resilience, and commercial execution to sustain growth and mitigate risk. First, diversify sourcing strategies by qualifying multiple suppliers and developing regional manufacturing options to reduce exposure to trade disruptions and tariff volatility. Investing in near-term dual sourcing and strategic inventory buffers can protect continuity while longer-term localization plans are implemented. Second, accelerate adoption of automation and closed-system designs where clinical and operational benefits justify capital allocation, while simultaneously offering cost-effective manual alternatives for low-volume or decentralized settings.

Third, prioritize material innovation and sustainability by evaluating alternatives that preserve analytical integrity while reducing environmental impact; engage with lifecycle assessment frameworks to demonstrate value to procurement partners. Fourth, enhance regulatory readiness through proactive engagement with authorities, strengthened post-market surveillance, and expedited pathways for clearance or conformity assessment, thereby shortening time-to-adoption in regulated markets. Fifth, embed commercial support services-training, technical assistance, and consumables management-into customer contracts to differentiate offerings and improve retention. Finally, align R&D investments with real-world clinical needs by co-developing solutions with leading laboratories and healthcare providers, ensuring product designs reflect end-user workflows and deliver demonstrable improvements in sample quality and patient safety. Taken together, these steps will help organizations convert insight into operational advantage and durable customer relationships.

A transparent methodological overview explaining primary stakeholder engagement, secondary synthesis, triangulation practices and quality assurance processes that underpin the analysis

The research underpinning this analysis combined qualitative stakeholder engagement with rigorous secondary synthesis and data triangulation to ensure balanced, actionable insights. Primary research included structured interviews with clinical laboratory leaders, procurement officers, manufacturing executives, and regulatory affairs specialists to capture first-hand perspectives on device performance, sourcing constraints, and adoption drivers. These conversations informed the taxonomy used to disaggregate product types, technologies, materials, applications, and end-user contexts, enabling targeted analysis that reflects operational realities.

Secondary sources were reviewed to contextualize regulatory trends, material science developments, and trade policy impacts, with careful attention to public regulatory documents, standards bodies publications, and peer-reviewed clinical literature. Triangulation techniques were applied to reconcile differing viewpoints and validate key conclusions, while sensitivity checks were used to surface alternative interpretations. Quality assurance processes included expert peer review and internal methodological audits to confirm consistency in definitions, inclusion criteria, and analytical logic. The research acknowledges limitations inherent to rapidly changing policy environments and heterogeneous regional data, and therefore emphasizes scenario-based insights and actionable recommendations rather than precise numerical projections.

A concise concluding synthesis that crystallizes strategic priorities, operational imperatives and the actions needed to realize clinical and commercial value across the ecosystem

In summary, the blood collection device landscape is undergoing meaningful transformation driven by technological innovation, heightened regulatory expectations, and evolving supply chain dynamics. These forces are reshaping product design priorities, accelerating adoption of automation in high-volume settings, and elevating the importance of resilient sourcing strategies in the face of trade policy shifts. At the same time, segmentation nuances-across product types, technologies, materials, clinical applications, and end-user contexts-underscore the need for tailored approaches that balance performance, cost, and compliance.

Organizations that proactively align R&D, manufacturing strategy, and commercial support models will be better positioned to meet clinical needs and navigate regulatory complexity. Leaders should prioritize supply diversification, invest in automation where appropriate, pursue sustainable material pathways, and strengthen regulatory engagement to accelerate access. By translating these insights into concrete actions, manufacturers and institutional buyers can improve operational continuity, enhance sample integrity, and deliver measurable clinical value. The conclusion invites decision-makers to use these findings to inform strategic planning and to mobilize resources that capitalize on emerging opportunities while managing downside risks effectively.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Collection Devices Market, by Product Type

  • 8.1. Blood Bags
  • 8.2. Blood Collection Needles
    • 8.2.1. Syringe Needles
    • 8.2.2. Vacuum Needles
  • 8.3. Blood Collection Tubes
    • 8.3.1. EDTA Tubes
    • 8.3.2. Heparin Tubes
    • 8.3.3. Plasma Blood Tubes
    • 8.3.4. Serum Tubes
  • 8.4. Blood Lancets

9. Blood Collection Devices Market, by Technology

  • 9.1. Automated Blood Collection Devices
  • 9.2. Manual Blood Collection Devices

10. Blood Collection Devices Market, by Material

  • 10.1. Glass
  • 10.2. Plastic
  • 10.3. Rubber
  • 10.4. Stainless Steel

11. Blood Collection Devices Market, by Application

  • 11.1. Diagnostics
  • 11.2. Therapeutics

12. Blood Collection Devices Market, by End Users

  • 12.1. Blood Donation Centers
  • 12.2. Diagnostic Centers & Pathology Laboratory
  • 12.3. Hospitals & Clinics

13. Blood Collection Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Blood Collection Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Blood Collection Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Blood Collection Devices Market

17. China Blood Collection Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. AdvaCare Pharma
  • 18.7. Avanos Medical, Inc.
  • 18.8. Avantor, Inc.
  • 18.9. B. Braun SE
  • 18.10. Becton, Dickinson and Company
  • 18.11. Bio-Rad Laboratories, Inc.
  • 18.12. Biosigma S.p.A.
  • 18.13. Cardinal Health, Inc.
  • 18.14. Exelint International, Co.
  • 18.15. Fresenius SE & Co. KGaA
  • 18.16. Greiner AG
  • 18.17. Haemonetics Corporation by GVS S.p.A.
  • 18.18. ICU Medical, Inc.
  • 18.19. Kawasumi Laboratories America, Inc.
  • 18.20. Lasany International
  • 18.21. Medtronic PLC
  • 18.22. Merit Medical Systems, Inc.
  • 18.23. Nipro Corporation
  • 18.24. Sarstedt AG & Co. KG
  • 18.25. Sekisui Medical Co., Ltd.
  • 18.26. Siemens Healthineers AG
  • 18.27. Terumo Corporation
  • 18.28. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD COLLECTION DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD COLLECTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BLOOD COLLECTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BLOOD COLLECTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY VACUUM NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY VACUUM NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY VACUUM NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY EDTA TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY EDTA TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY EDTA TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HEPARIN TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HEPARIN TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HEPARIN TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASMA BLOOD TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASMA BLOOD TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASMA BLOOD TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SERUM TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SERUM TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SERUM TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD LANCETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD LANCETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD LANCETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY AUTOMATED BLOOD COLLECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY AUTOMATED BLOOD COLLECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY AUTOMATED BLOOD COLLECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MANUAL BLOOD COLLECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MANUAL BLOOD COLLECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MANUAL BLOOD COLLECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY RUBBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY RUBBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY RUBBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD DONATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD DONATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD DONATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & PATHOLOGY LABORATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & PATHOLOGY LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & PATHOLOGY LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 146. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 149. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 150. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 152. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 170. G7 BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 173. G7 BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 174. G7 BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. G7 BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 176. G7 BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. G7 BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 178. NATO BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NATO BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 181. NATO BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 182. NATO BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. NATO BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 184. NATO BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. NATO BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES BLOOD COLLECTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA BLOOD COLLECTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)